HARBIN GLORIA PHARMACEUTICALS CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.02 CNY | +0.50% |
|
-0.98% | -19.52% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
HARBIN GLORIA PHARMACEUTICALS Co., LTD is a China-based company, principally engaged in the manufacture and distribution of pharmaceuticals. The Company's products include cardiovascular and cerebrovascular drugs, orthopedic drugs, nutritional drugs, anti-infective drugs, immune-enhancing drugs, diabetes drugs, antineoplastic drugs and electrolytes drugs. The Company is also engaged in the agency, research and development of pharmaceuticals, the provision of clinical services and financial investment business. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -19.52% | 633M | |
| +20.70% | 42.78B | |
| +18.59% | 22.25B | |
| +14.49% | 14.39B | |
| +12.83% | 13.55B | |
| +38.02% | 11.27B | |
| -9.80% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.29% | 5.01B |
- Stock Market
- Equities
- 002437 Stock
- News Harbin Gloria Pharmaceuticals Co., Ltd
- Harbin Gloria Pharma Swings to Loss in 2022 on Asset Impairment
